|
|
|
Volumn 9, Issue 24, 2005, Pages 213-215
|
|
Relationship between blood glucose levels in patients with type 2 diabetes mellitus, depression and anxiety and the anti-depression/anxiety intervention
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALPRAZOLAM;
ANTIDEPRESSANT AGENT;
ANTIDIABETIC AGENT;
ANXIOLYTIC AGENT;
GLUCOSE;
GLYCOSYLATED HEMOGLOBIN;
HEMOGLOBIN A1C;
INSULIN;
PAROXETINE;
PSYCHOTROPIC AGENT;
ADULT;
ANXIETY DISORDER;
ARTICLE;
CLINICAL ARTICLE;
CLINICAL PSYCHOLOGY;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DEPRESSION;
DIET RESTRICTION;
DRUG DOSE REGIMEN;
DRUG EFFICACY;
DRUG HYPERSENSITIVITY;
ECONOMIC ASPECT;
ENDOCRINOLOGY;
EXPERIMENTATION;
FEMALE;
GLUCOSE BLOOD LEVEL;
GLUCOSE METABOLISM;
HOSPITAL DEPARTMENT;
HUMAN;
INSULIN RESISTANCE;
MALE;
MOOD DISORDER;
NON INSULIN DEPENDENT DIABETES MELLITUS;
OUTCOMES RESEARCH;
PATIENT COMPLIANCE;
POSTPRANDIAL STATE;
PUBLIC HOSPITAL;
RANDOMIZED CONTROLLED TRIAL;
RATING SCALE;
SCORING SYSTEM;
SELF CONCEPT;
STATISTICAL SIGNIFICANCE;
UNIVERSITY HOSPITAL;
VOLUNTEER;
|
|
EID: 27644436427
PISSN: 16715926
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (5)
|
|
References (5)
|
